News Focus
News Focus
icon url

biopharm

03/19/15 2:21 PM

#211842 RE: biopharm #201399

Hakan Mellstedt : Peregrine Pharmaceuticals KOL

.... ok, so lately we've brought in some puzzle pieces for Greg Lemke <> Xetrios <> Salks Institute and a PS Targeting Patent and all other associated patents of Lemkes's and Salks all sold to "Kolltan"

so the puzzle gets bigger but at least we have a tie from Hakan Mellstedt to Gerald McMahon CEO of Kolltan...and PAV lists of some have shown Standish Fleming as well

enough for today..

-------------------------------------

Gordon Rustin M.D., MSc, FRCP Return to Angstrom Pharmaceuticals, Inc.
Member of Clinical Trial Advisory Board




David J. Chaplin
OXiGENE, Inc.
Board Affiliations
OXiGENE, Inc.

Tamar D. Howson
S*BIO Pte Ltd.
Board Affiliations
OXiGENE, Inc.

Adrian Lewellyn Harris
Collgard Biopharmaceuticals Ltd.
Board Affiliations
OXiGENE, Inc.
Angstrom Pharmaceuticals, Inc.

Frederick W. Driscoll
Flexion Therapeutics, Inc.
Board Affiliations
OXiGENE, Inc.

Gerald McMahon
Kolltan Pharmaceuticals, Inc.
Board Affiliations
OXiGENE, Inc.


Robert S. Kerbel
MetronomX, Pte. Ltd.
Board Affiliations
OXiGENE, Inc.

William D. Schwieterman
Avidia, Inc.
Board Affiliations
OXiGENE, Inc.

Stanley Kaye
Biotica Technology Limited
Board Affiliations
OXiGENE, Inc.

Dietmar W. Siemann
OXiGENE, Inc.
Board Affiliations
OXiGENE, Inc.

Jan B. Vermorken
Vaccinogen, Inc.
Board Affiliations
OXiGENE, Inc.

Lee S. Rosen
OXiGENE, Inc.
Board Affiliations
OXiGENE, Inc.

Hakan Mellstedt
Korea Stem Cell Bank Co., Ltd
Board Affiliations
OXiGENE, Inc.


Jeffrey S. Heier
Ophthalmic Consultants of Boston, Inc.
Board Affiliations
OXiGENE, Inc.

Hilary Calvert
Astex Therapeutics Limited
Board Affiliations
OXiGENE, Inc.

Standish M. Fleming
Forward Ventures
Board Affiliations
Nereus Pharmaceuticals, Inc.


Jason S. Fisherman
Synthesis Capital
Board Affiliations
Nereus Pharmaceuticals, Inc.

Erich Platzer
HBM Partners Ltd.
Board Affiliations
Nereus Pharmaceuticals, Inc.

Frank V. AtLee
Agenus Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.

Jim Van Heusden
Karolinska Development AB (publ)
Board Affiliations
Nereus Pharmaceuticals, Inc.

Martin Rosenberg
VantagePoint Capital Partners
Board Affiliations
Nereus Pharmaceuticals, Inc.

Gary Shearman
Neuro-Hitech, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.

Kenneth C. Anderson
OncoPep, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.

Lee Ellis
Cerulean Pharma Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.

Kobi M. Sethna
Nereus Pharmaceuticals, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.

John C. Byrd
Nereus Pharmaceuticals, Inc.
Board Affiliations
Nereus Pharmaceuticals, Inc.

Peter O'Dwyer
TetraLogic Pharmaceuticals Corporation
Board Affiliations
Nereus Pharmaceuticals, Inc.

Martin Nash
Genetronics Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

David C. U'Prichard
Druid Consulting, LLC
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Donald W. Grimm
Aegis Therapeutics, LLC
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Virgil D. Thompson
Spinnaker Biosciences, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

James A. Taylor
Innate Immunotherapeutics Limited
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Stephen B. Howell
Aptose Biosciences Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Malcolm J. P. Finlayson
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Kerry Dance
Hamilton BioVentures
Board Affiliations
Angstrom Pharmaceuticals, Inc.

William R. Freeman
Spinnaker Biosciences, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Bruce Dezube
Collgard Biopharmaceuticals Ltd.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Michael H. Silverman
Can-Fite BioPharma Ltd.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Nils Brünner
WntResearch AB
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Jennifer Lorenzen
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Frederick E. Reno
Innate Immunotherapeutics Limited
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Chi Yap
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

Arup Das
Angstrom Pharmaceuticals, Inc.
Board Affiliations
Angstrom Pharmaceuticals, Inc.

http://webcache.googleusercontent.com/search?q=cache:ymEFCzMQlAwJ:www.bloomberg.com/research/stocks/people/relationship.asp%3FpersonId%3D26576928%26ticker%3DOXGN%26previousCapId%3D1635374%26previousTitle%3DAngstrom%2520Pharmaceuticals%252C%2520Inc.+&cd=2&hl=en&ct=clnk&gl=us
icon url

biopharm

04/19/15 2:07 AM

#216036 RE: biopharm #201399

Rolf A. Stahel is current President of ESMO...



Interesting video below re: Rolf Stahel as he states:

"Everybody develops cancer all the time and the immune system gets rid of it. However, the tumors have developed mechanisms that they can fight off the immune system and they can find ways by secreting factors which block the immune cells or by having on the surface, receptors, which when the immune cells hit those receptors, they go inactive. Now, Immuno-Oncology is the idea to enable the immune system to fight back the cancer.."

"Immuno-Oncology for most of the part is clinical trials, but there have been agents - immune checkpoint inhibitors that have regulatory approval for clinical use. The thing is though, the results are...good, but there is so much more hope for better results that I would think that most of the physicians or centers that deal with Immuno-Oncology would like to treat the patient in trials to give him an even better chance than what is already available"



http://www.ecpc.org/Documents/Policy&Advocacy/Immuno-Oncology/Event%2019th%20Nov%202014/IO%20patients%20leaflet.pdf



Did everyone in the boat hear that?

"I would think that most of the physicians or centers that deal with Immuno-Oncology would like to treat the patient in trials to give him an even better chance that what is already available"

...and that is coming from the President of the ESMO and sure sounds like this paradigm shift in medical treatment is happening so fast, that if the docs are aware of what is looming out there in PS Targeting land, that trials are where you will find your best chance for an even better chance than what is already available.